Comparison of vascular response to zotarolimus-eluting stent vs paclitaxel-eluting stent implantation- Pooled IVUS results from the zomaxx i and ii trials

Circulation Journal

Volumn 74, Issue 11, 2010, Pages 2334-2339

  Waseda, Katsuhisa ^a   Hasegawa, Takao ^a   Ako, Junya ^a   Honda, Yasuhiro ^a   Grube, Eberhard ^b   Whitbourn, Robert ^c   Ormiston, John ^d   O'Shaughnessy, Charles D ^e   Henry, Timothy D ^f   Overlie, Paul ^g   Schwartz, Lewis B ^h   Sudhir, Krishnankutty ⁱ   Chevalier, Bernard ^j   Gray, William A ^k   Yeung, Alan C ^a   Fitzgerald, Peter J ^a  

^a STANFORD UNIVERSITY   (United States)

^b HELIOS Heart Center   (United States)

^c ST VINCENT S HOSPITAL   (Australia)

^d AUCKLAND CITY HOSPITAL   (New Zealand)

^e Elyria Memorial Hospital   (United States)

^f ABBOTT NORTHWESTERN HOSPITAL   (United States)

^g Lubbock Heart Hospital   (United States)

^h ABBOTT LABORATORIES   (United States)

ⁱ ABBOTT VASCULAR   (United States)

^j CENTRE CARDIOLOGIQUE DU NORD   (France)

^k Och Spine at New York Presbyterian Hospitals   (United States)

more..

Author keywords

Coronary artery disease; Drug eluting stent; Intravascular ultrasound

Indexed keywords

PACLITAXEL; ZOTAROLIMUS;

ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROTIC PLAQUE; CLINICAL TRIAL; CORONARY ARTERY OBSTRUCTION; DRUG ELUTING STENT; FOLLOW UP; HUMAN; INCIDENCE; INTRAVASCULAR ULTRASOUND; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; RESTENOSIS;

AGED; ANGIOPLASTY, BALLOON, CORONARY; CARDIOVASCULAR AGENTS; CHI-SQUARE DISTRIBUTION; CORONARY ANGIOGRAPHY; CORONARY RESTENOSIS; CORONARY VESSELS; DRUG-ELUTING STENTS; FEMALE; HUMANS; HYPERPLASIA; MALE; MIDDLE AGED; MULTICENTER STUDIES AS TOPIC; PACLITAXEL; PROSTHESIS DESIGN; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK ASSESSMENT; RISK FACTORS; SIROLIMUS; TIME FACTORS; TREATMENT OUTCOME; TUNICA INTIMA; ULTRASONOGRAPHY, INTERVENTIONAL;

EID: 77958047015     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-09-0850     Document Type: Article

References (26)

1. Abizaid A, Lansky AJ, Fitzgerald PJ, Tanajura LF, Feres F, Staico R, et al. Percutaneous coronary revascularization using a trilayer metal phosphorylcholine-coated zotarolimus-eluting stent. Am J Cardiol 2007; 99: 1403-1408.
2. Chevalier B, Di Mario C, Neumann FJ, Ribichini F, Urban P, Popma JJ, et al. A randomized, controlled, multicenter trial to evaluate the safety and efficacy of zotarolimus- versus paclitaxel-eluting stents in de novo occlusive lesions in coronary arteries The ZoMaxx I trial. J Am Coll Cardiol Intv 2008; 1: 524-532.
3. Kataoka T, Grube E, Honda Y, Morino Y, Hur SH, Bonneau HN, et al. 7-hexanoyltaxol-eluting stent for prevention of neointimal growth: An intravascular ultrasound analysis from the Study to COmpare REstenosis rate between QueST and QuaDS-QP2 (SCORE). Circulation 2002; 106: 1788-1793.
4. Ako J, Morino Y, Honda Y, Hassan A, Sonoda S, Yock PG, et al. Late incomplete stent apposition after sirolimus-eluting stent implantation: A serial intravascular ultrasound analysis. J Am Coll Cardiol 2005; 46: 1002-1005.
5. Honda Y. Drug-eluting stents. Insights from invasive imaging technologies. Circ J 2009; 73: 1371-1380.
6. Moses JW, Leon MB, Popma JJ, Fitzgerald PJ, Holmes DR, O'Shaughnessy C, et al. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery. N Engl J Med 2003; 349: 1315-1323.
7. Weissman NJ, Koglin J, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, et al. Polymer-based paclitaxel-eluting stents reduce instent neointimal tissue proliferation: A serial volumetric intravascular ultrasound analysis from the TAXUS-IV trial. J Am Coll Cardiol 2005; 45: 1201-1205.
8. Stone GW, Ellis SG, Cox DA, Hermiller J, O'Shaughnessy C, Mann JT, et al. One-year clinical results with the slow-release, polymerbased, paclitaxel-eluting TAXUS stent: The TAXUS-IV trial. Circulation 2004; 109: 1942-1947.
9. Sousa JE, Costa MA, Sousa AG, Abizaid AC, Seixas AC, Abizaid AS, et al. Two-year angiographic and intravascular ultrasound follow-up after implantation of sirolimus-eluting stents in human coronary arteries. Circulation 2003; 107: 381-383.
10. Sakurai R, Hongo Y, Yamasaki M, Honda Y, Bonneau HN, Yock PG, et al. Detailed intravascular ultrasound analysis of Zotarolimuseluting phosphorylcholine-coated cobalt-chromium alloy stent in de novo coronary lesions (results from the ENDEAVOR II trial). Am J Cardiol 2007; 100: 818-823.
11. Miyazawa A, Ako J, Hongo Y, Hur SH, Tsujino I, Courtney BK, et al. Comparison of vascular response to zotarolimus-eluting stent versus sirolimus-eluting stent: Intravascular ultrasound results from ENDEAVOR III. Am Heart J 2008; 155: 108-113.
12. Waseda K, Miyazawa A, Ako J, Hasegawa T, Tsujino I, Sakurai R, et al. Intravascular ultrasound results from the ENDEAVOR IV trial: Randomized comparison between zotarolimus- and paclitaxel-eluting stents in patients with coronary artery disease. J Am Coll Cardiol Intv 2009; 2: 779-784.
13. Colombo A, Orlic D, Stankovic G, Corvaja N, Spanos V, Montorfano M, et al. Preliminary observations regarding angiographic pattern of restenosis after rapamycin-eluting stent implantation. Circulation 2003; 107: 2178-2180.
14. Escolar E, Mintz GS, Popma J, Michalek A, Kim SW, Mandinov L, et al. Meta-analysis of angiographic versus intravascular ultrasound parameters of drug-eluting stent efficacy (from TAXUS IV, V, and VI). Am J Cardiol 2007; 100: 621-626.
15. Kotani J, Awata M, Nanto S, Uematsu M, Oshima F, Minamiguchi H, et al. Incomplete neointimal coverage of sirolimus-eluting stents: Angioscopic findings. J Am Coll Cardiol 2006; 47: 2108-2111.
16. Joner M, Finn AV, Farb A, Mont EK, Kolodgie FD, Ladich E, et al. Pathology of drug-eluting stents in humans: Delayed healing and late thrombotic risk. J Am Coll Cardiol 2006; 48: 193-202.
17. Kataiwa H, Tanaka A, Kitabata H, Imanishi T, Akasaka T. Safety and usefulness of non-occlusion image acquisition technique for optical coherence tomography. Circ J 2008; 72: 1536-1537.
18. Shimohama T, Ako J, Yamasaki M, Otake H, Tsujino I, Hasegawa T, et al. SPIRIT III JAPAN versus SPIRIT III USA: A comparative intravascular ultrasound analysis of the everolimus-eluting stent. Am J Cardiol 2010; 106: 13-17.
19. Tanabe K, Serruys PW, Degertekin M, Guagliumi G, Grube E, Chan C, et al. Chronic arterial responses to polymer-controlled paclitaxeleluting stents: Comparison with bare metal stents by serial intravascular ultrasound analyses: Data from the randomized TAXUS-II trial. Circulation 2004; 109: 196-200.
20. Weissman NJ, Ellis SG, Grube E, Dawkins KD, Greenberg JD, Mann T, et al. Effect of the polymer-based, paclitaxel-eluting TAXUS Express stent on vascular tissue responses: A volumetric intravascular ultrasound integrated analysis from the TAXUS IV, V, and VI trials. Eur Heart J 2007; 28: 1574-1582.
21. Finn AV, Kolodgie FD, Harnek J, Guerrero LJ, Acampado E, Tefera K, et al. Differential response of delayed healing and persistent inflammation at sites of overlapping sirolimus- or paclitaxeleluting stents. Circulation 2005; 112: 270-278.
22. Hong MK, Mintz GS, Lee CW, Park DW, Park KM, Lee BK, et al. Late stent malapposition after drug-eluting stent implantation: An intravascular ultrasound analysis with long-term follow-up. Circulation 2006; 113: 414-419.
23. Degertekin M, Serruys PW, Tanabe K, Lee CH, Sousa JE, Colombo A, et al. Long-term follow-up of incomplete stent apposition in patients who received sirolimus-eluting stent for de novo coronary lesions: An intravascular ultrasound analysis. Circulation 2003; 108: 2747-2750.
24. Tanabe K, Serruys PW, Degertekin M, Grube E, Guagliumi G, Urbaszek W, et al. Incomplete stent apposition after implantation of paclitaxel-eluting stents or bare metal stents: Insights from the randomized TAXUS II trial. Circulation 2005; 111: 900-905.
25. Feres F, Costa JR Jr, Abizaid A. Very late thrombosis after drugeluting stents. Catheter Cardiovasc Interv 2006; 68: 83-88.
26. Cook S, Wenaweser P, Togni M, Billinger M, Morger C, Seiler C, et al. Incomplete stent apposition and very late stent thrombosis after drug-eluting stent implantation. Circulation 2007; 115: 2426-2434.